These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3987718)

  • 1. Intestinal perforation associated with indomethacin treatment in premature infants.
    Kühl G; Wille L; Bolkenius M; Seyberth HW
    Eur J Pediatr; 1985 Jan; 143(3):213-6. PubMed ID: 3987718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants.
    Nagaraj HS; Sandhu AS; Cook LN; Buchino JJ; Groff DB
    J Pediatr Surg; 1981 Dec; 16(6):1003-7. PubMed ID: 7338750
    [No Abstract]   [Full Text] [Related]  

  • 3. Indomethacin and recurrent ileal perforations in a preterm infant.
    Giacoia GP; Azubuike K; Taylor JR
    J Perinatol; 1993; 13(4):297-9. PubMed ID: 8410386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized intestinal perforations after enteral administration of indomethacin in premature infants.
    Alpan G; Eyal F; Vinograd I; Udassin R; Amir G; Mogle P; Glick B
    J Pediatr; 1985 Feb; 106(2):277-81. PubMed ID: 3968618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
    O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
    J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants.
    Sivanandan S; Bali V; Soraisham AS; Harabor A; Kamaluddeen M
    Am J Perinatol; 2013 Oct; 30(9):745-50. PubMed ID: 23322388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.
    Grosfeld JL; Chaet M; Molinari F; Engle W; Engum SA; West KW; Rescorla FJ; Scherer LR
    Ann Surg; 1996 Sep; 224(3):350-5; discussion 355-7. PubMed ID: 8813263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized intestinal perforation following intravenous indomethacin in premature infants.
    Wolf WM; Snover DC; Leonard AS
    J Pediatr Surg; 1989 Apr; 24(4):409-10. PubMed ID: 2732888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin.
    Mellander M; Leheup B; Lindstrom DP; Palme C; Graham TP; Stahlman MT; Cotton RB
    J Pediatr; 1984 Jul; 105(1):138-43. PubMed ID: 6737129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized intestinal perforation following intravenous indomethacin for patent ductus arteriosus.
    Scholz TD; McGuinness GA
    J Pediatr Gastroenterol Nutr; 1988; 7(5):773-5. PubMed ID: 3183883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin.
    Madan J; Fiascone J; Balasubramanian V; Griffith J; Hagadorn JI
    Neonatology; 2008; 94(1):45-51. PubMed ID: 18196930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin for closure of patent ductus arteriosus in prematures.
    Mullett MD; Croghan TW; Myerberg DZ; Krall JM; Neal WA
    Clin Pediatr (Phila); 1982 Apr; 21(4):217-20. PubMed ID: 7039927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates.
    Paquette L; Friedlich P; Ramanathan R; Seri I
    J Perinatol; 2006 Aug; 26(8):486-92. PubMed ID: 16791261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L; Nankervis CA; Delooze D; Giannone PJ
    J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment.
    Little DC; Pratt TC; Blalock SE; Krauss DR; Cooney DR; Custer MD
    J Pediatr Surg; 2003 Mar; 38(3):492-6. PubMed ID: 12632374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.
    Walters M
    BMJ; 1988 Sep; 297(6651):773-4. PubMed ID: 3142543
    [No Abstract]   [Full Text] [Related]  

  • 18. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological closure of ductus arteriosus in preterm infants using indomethacin.
    Obeyesekere HI; Pankhurst S; Yu VY
    Arch Dis Child; 1980 Apr; 55(4):271-6. PubMed ID: 7416776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.